Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

RestorLife Med review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

RestorLife's plan cards read $149, $209 and $199 a month for the same compounded semaglutide, and the cheapest one is the one-month plan — which should tell you the numbers are not what they look like. They are blended averages: the site's own labels say "50% off your first month" and "50% off month 1, then 20% off", so the discount is folded into every figure. Work it through and the standard price is $299 a month, and from month two you pay $299, $239 or $209 depending on the term you signed. The mechanism is disclosed; the arithmetic is left to you.

$149to start

then $299/mo ongoing

Consult Medication Shipping
See plans at RestorLife Med
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

RestorLife Med at a glance

Semaglutide
$299/mo standard rate
Tirzepatide
$399/mo standard rate
Coverage
Not published on the site
Brand-name
Compounded only

How we scored RestorLife Med

Every factor comes from RestorLife Med's own published pricing, disclosures and oversight, and the six combine into the 31/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

True monthly cost30/100 · Weak

Cost is unpredictable or sits at the premium end.

Postpartum & breastfeeding guidance18/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit34/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Ongoing support44/100 · Weak

Support is thin once the prescription ships.

Clinical oversight & labs36/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

Cancellation fairness24/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

The plan cards advertise $149, $209 and $199 a month for compounded semaglutide, but the site's own labels — "50% off your first month" and "50% off month 1, then 20% off" — mean those are averages that include the one-time discount. The list price is $299 a month, and the recurring charge from month two is $299, $239 or $209 depending on the term. Tirzepatide works the same way off a $399 list. The Terms bill approximately every 28 to 30 days, state that the fee is non-refundable once paid, and name no operating company.

Before you sign up

What RestorLife Med's public site and signup page show before you hand over any details.

Worth knowing

  • The intake runs on Bask Health rather than on the provider's own software
  • No monthly price is visible on the public homepage; the number appears only after you begin the intake

Pricing

MedicationPricePlan
Compounded semaglutide$149 → $299One-month plan"1 Month — 50% off your first month — $149/mo, $299/mo." The $149 is the first month only.
Compounded semaglutide$239Three-month planAdvertised as $209/mo, but that is the average across the term: "50% off month 1, then 20% off" means $149.50 once and $239.20 for months two and three.
Compounded semaglutide$209Six-month planAdvertised as $199/mo. "50% off month 1, then 30% off" gives $149.50 once and $209.30 for months two through six.
Compounded semaglutide$99 → $199Microdose, one-month plan"Weight Loss Micro — 1 Month, Billed monthly — $99/mo, $199/mo." A quarterly option shows $56/mo against a $113 list. Unlike the full-dose cards, these carry no first-month qualifier.
Compounded tirzepatide$199 → $399One-month plan"1 Month — 50% off your first month — $199/mo, $399/mo."
Compounded tirzepatide$319Three-month planAdvertised as $279/mo — the average of $199.50 for month one and $319.20 for months two and three.
Compounded tirzepatide$279Six-month planAdvertised as $265/mo — the average of $199.50 once and $279.30 for months two through six.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what RestorLife Med's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • Each product has its own page with the discount structure spelled out — "50% off month 1, then 20% off" — rather than a bare promotional price
  • The full list price is printed beside every discounted figure, so nothing is hidden outright
  • A microdose tier is offered as a genuinely cheaper entry point at $99 a month against a $199 list
  • Free priority shipping in discreet packaging, and a physician consultation is included in the plan
  • Links out to the LegitScript checker for its own domain

The caveats

  • The "/mo" figures on the three- and six-month plans are blended averages that include the one-time first-month discount — the recurring charge is $239 and $209 for semaglutide, and $319 and $279 for tirzepatide
  • The one-month plan's $149 applies to the first month only; it is $299 after that
  • The Terms bill "on a recurring, monthly basis (approximately every 28-30 days)", which at the short end is thirteen charges in a year rather than twelve
  • "Once paid, your Membership Fee is non-refundable"
  • No operating company is named anywhere on the site or in its Terms — only "© 2026 RestorLife Med"
  • Two different support numbers appear — (708) 775-3734 on the site and (331) 444-7000 in the Terms
  • No list of states served is published

The ordinary plan starts below its continuing price

RestorLife Med’s one-month program advertises compounded semaglutide at $149 for the first month, then $299, and tirzepatide at $199 initially, then $399. These are the August public plan terms, not a newly confirmed October offer. The introductory payment should not stand in for the continuing budget simply because it is the more prominent number in a product card.

The broader storefront also contains hormone, sermorelin and other wellness products with overlapping prices. A $149 card elsewhere may describe a different medication. Begin with the named semaglutide or tirzepatide program, then obtain the current prescription-specific total, quantity and renewal schedule rather than borrowing a figure from the general catalog.

Longer-plan averages blend unequal payments

The three-month semaglutide offer is advertised around $209 per month, and the six-month offer around $199. Those are blended figures that combine a larger first-month discount with smaller later discounts. They do not establish that every payment within either term is the advertised average or that the same amount applies to a flexible single-month purchase.

The stated percentage discounts imply later semaglutide payments of approximately $239.20 on the three-month term or $209.30 on the six-month term; tirzepatide’s corresponding amounts are approximately $319.20 and $279.30. Because the cards round their figures, request the actual dollar-by-dollar payment schedule rather than treating the calculation as a confirmed checkout total. The term, initial payment and later charges belong together.

The microdose card uses a different presentation

RestorLife also lists a microdose program, with monthly and quarterly descriptions that do not use the same explicit first-month wording as the standard programs. It should be assessed as its own offer, not substituted for standard treatment to create a lower comparison price. Ask the clinician what medication and quantity it provides and why it is being proposed.

The presence of a lower-dose option does not establish equivalent outcomes, improved tolerability or suitability for an individual. Likewise, buying a longer plan is a financial choice rather than a clinical instruction to continue unchanged. Establish how a prescription change affects payment and remaining supply before committing to a term whose apparent saving depends on using several months.

Monthly renewal needs a date, not just a label

The terms describe recurring monthly membership billing approximately every twenty-eight to thirty days, with paid membership fees nonrefundable. That range deserves clarification alongside an ordinary monthly product label. Ask for the next charge date and the schedule that follows it, rather than assuming the anniversary date will remain fixed on the calendar.

Also obtain the cancellation method and deadline before another charge or pharmacy order. Stopping future membership and refunding medication already dispensed are separate questions. Clarify how the clinical team handles a treatment interruption and whether canceling one component stops every related payment. The nonrefundable-fee statement makes it important to understand the commitment before a charge occurs.

Identify the practice behind the storefront

RestorLife’s available legal pages do not clearly identify an operating company or street address, and two different support numbers appear. No state list is published. Ask for the actual seller, treating practice, assigned clinician and dispensing pharmacy, and confirm which contact handles billing versus clinical questions.

RestorLife may interest someone willing to evaluate a defined multi-month offer carefully, but its pricing cannot be reduced to the smallest monthly average. A clear current quote should resolve the discounted payment schedule, renewal dates, supply and follow-up. The useful comparison keeps standard treatment, microdose care and unrelated catalog products separate, with the actual commitment and responsible care team visible before purchase.

The bottom line for mothers

Best for: Someone willing to do the multiplication before the second charge lands.

Alternatives to RestorLife Med

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • A compounded program that advertises ongoing provider care, metabolic testing every six months and shipping within its price. Semaglutide is $249 and tirzepatide $329 every four weeks without a longer commitment; lower equivalents require 12-, 24- or 48-week terms. Microdose and combination options need separate current quotes.

    Visit Enhance MD
  • Compounded medication with clinician access and coaching, with semaglutide shown at $299 regular and $79 on a time-limited sale. The important commitment comes before the eligibility decision: payment is taken first, paid terms are generally non-refundable, and medical disqualification refunds only the unused portion after deductions.

    Visit Embody

Providers like RestorLife Med

Keep comparing RestorLife Med

RestorLife Med, answered

How much does RestorLife Med cost?
At last review, RestorLife Med's lowest ongoing compounded rate was about $299/mo — $299/mo standard rate for semaglutide, $399/mo standard rate for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
Is RestorLife Med safe to use while breastfeeding?
No GLP-1 is established as safe in pregnancy. Nursing is less clear-cut. The Wegovy injection, Ozempic, Zepbound and Mounjaro labels have little or no breast-milk data and ask you and your clinician to weigh the benefits of breastfeeding against how much you need the drug. Compounded versions carry no label of their own, which puts more of that judgment on your prescriber. RestorLife Med is not an exception to any of that — settle the timing with your own clinician.
Does RestorLife Med offer both semaglutide and tirzepatide?
Yes — RestorLife Med offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
How does RestorLife Med score for mothers?
RestorLife Med scores 31/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.

Pricing, states and verification reflect RestorLife Med's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers